As wellness conversations broaden beyond abstinence, new research explores cannabis through a harm-reduction lens and what it could mean for moderating alcohol consumption.
The move to Schedule III marks the greatest change to U.S. drug laws since the Controlled Substances Act in 1970 and represents a new future for the $32 billion cannabis industry.